Women's Health

Reed S, Getahun D, Gatz J, Armstrong M, Raine-Bennett T, Zhou X, Fassett M, Peipert J, Saltus CW, Im T, Alabaster A, Hunter S, Takhar H, Chillemi G, Xie F, Wang J, Chiu V, Frenz A, Shi J, Lynen R, Asiimwe A, Anthony MS. Postpartum timing of IUD insertion is associated with risk of uterine perforation: results from APEX IUD. Poster presented at the Society of Family Planning Virtual 2020 Annual Meeting; October 9, 2020. [abstract] Contraception. 2020 Oct; 102(4):302. doi: 10.1016/j.contraception.2020.07.099

OBJECTIVES: To evaluate the association of postpartum timing of intrauterine device (IUD) insertion with risk of uterine perforation.

DePree B, Houghton K, Shiozawa A, Esterberg E, Kim J, Mancuso S. Real-world treatment for menopausal symptoms in the US by practitioner type. Poster presented at the American College of Obstetricians and Gynecologists (ACOG) 2022 Annual Meeting; May 6, 2022. San Diego, CA.

INTRODUCTION: Vasomotor symptoms are the most common menopausal symptoms for which women seek treatment. We describe current treatment use by practitioner type (gynecologists vs primary care providers [PCPs]) and US geographic region.

Graham S, Constantine G, Margulis AV, Saltus CW, Johannes CB, Kaye JA, Mirkin S. A postmarketing noninterventional study evaluating the risk of endometrial cancer in women who have been prescribed Imvexxy® - study design. Poster presented at the 2021 North American Menopause Society (NAMS) Annual Meeting; September 22, 2021. [abstract] Menopause. 2021; 28(12):1462(P28). doi: 10.1097/GME.0000000000001890

Anderson S, Mauskopf J, Talbird SE, White A, Meenakshi S. Antiseizure medications and oral contraceptives: impact of enzyme inducers on pregnancy outcomes and costs. Epilepsy Behav. 2021 Dec;125:108368. doi: 10.1016/j.yebeh.2021.108368

PURPOSE: To show the impact of drug-drug interactions (DDIs) associated with co-administration of enzyme-inducing (EI) antiseizure medications and oral contraceptives (OCs) on the annual number of unintended pregnancies, their outcomes, and their associated costs in the United States (US).

Ferrer C, Garcia-Esteban R, Mendez M, Romieu I, Torrent M, Sunyer J. Social determinants of dietary patterns during pregnancy. Gac Sanit. 2009 Jan;23(1):38-43. doi: 10.1016/j.gaceta.2008.05.004

OBJECTIVES: To identify dietary patterns in pregnancy and describe their relationship with sociodemographic factors, smoking, and body mass index. As a secondary objective, intakes were evaluated relative to current dietary recommendations for pregnant women.

Alvarez-Pedrerol M, Ribas-Fito N, Garcia-Esteban R, Rodriguez A, Soriano D, Guxens M, Mendez M, Sunyer J. Iodine sources and iodine levels in pregnant women from an area without known iodine deficiency. Clin Endocrinol (Oxf). 2010 Jan;72(1):81-6. doi: 10.1111/j.1365-2265.2009.03588.x

Aguilera I, Guxens M, Garcia-Esteban R, Corbella T, Nieuwenhuijsen MJ, Foradada CM, Sunyer J. Association between GIS-based exposure to urban air pollution during pregnancy and birth weight in the INMA Sabadell Cohort. Environ Health Perspect. 2009 Aug;117(8):1322-7. doi: 10.1289/ehp.0800256

BACKGROUND: There is growing evidence that traffic-related air pollution reduces birth weight. Improving exposure assessment is a key issue to advance in this research area.

Aguilera I, Garcia-Esteban R, Iniguez C, Nieuwenhuijsen MJ, Rodríguez A, Paez M, Ballester F, Sunyer J. Prenatal exposure to traffic-related air pollution and ultrasound measures of fetal growth in the INMA Sabadell cohort. Environ Health Perspect. 2010 May;118(5):705-11. doi: 10.1289/ehp.0901228

BACKGROUND: Few studies have used longitudinal ultrasound measurements to assess the effect of traffic-related air pollution on fetal growth.

Hellwig K, Magyari M, McDonald T, Gembert K, Wergeland S, Leinonen MK, Aydemir A, Sabido M, Kawai A, Arana A. A multi-country cohort database study to assess pregnancy and infant outcomes in women exposed to cladribine tablets: CLEAR study. Poster presented at the 2021 Digital 37th Conference of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS); October 13, 2021.

INTRODUCION: Cladribine tablets are contraindicated during pregnancy.

OBJECTIVES: CLEAR (EUPAS25027) is a cohort study that aims to determine whether exposure to cladribine tablets has an adverse effect on pregnancy and infant outcomes.

Sunyer J, Garcia-Esteban R, Alvarez M, Guxens M, Goni F, Basterrechea M, Vrijheid M, Guerra S, Anto JM. DDE in mothers' blood during pregnancy and lower respiratory tract infections in their infants. Epidemiology. 2010 Sep;21(5):729-35. doi: 10.1097/EDE.0b013e3181e5ea96

Subscribe to Women's Health